marketcaparena

NRXP

NRX Pharmaceuticals, Inc.

Company overview

Market capitalization
$124.26M
Employees
29
Latest publication
2026-09-29
About NRX Pharmaceuticals, Inc.

NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder (PTSD), and schizophrenia in the United States. It operates through NRx and Dura segments. The company develops NRX-101, an oral fixed-dose combination of D-cycloserine (DCS) and lurasidone in Phase 2/3 clinical testing for bipolar depression with sub-acute ideation and behavior; NRX-100, a preservative-free formulation of ketamine for intravenous infusion and for the treatment of suicidal depression; and KETAFREE, a generic preservative-free formulation of ketamine. It also provides precision-based interventional psychiatry services to patients with treatment-resistant depression and PTSD using a combination of neuroplastic drugs, transcranial magnetic stimulation (TMS), digital therapeutics, and hyperbaric therapy; ketamine infusion therapy; stellate ganglion blocks; Spravato administration; psychotherapy; and medication management. The company has a development and license agreement with Glytech LLC. NRx Pharmaceuticals, Inc. was founded in 2015 and is headquartered in Wilmington, Delaware.

Company website

Financial statements

Income Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
Total Revenue1,101,000USD1,068,000USD983,000USD242,000USD0USD4,000USD4,000USD0USD
Cost Of Revenue675,000USD796,000USD508,000USD138,000USD—2,000USD1,000USD2,000USD
Gross Profit426,000USD272,000USD475,000USD104,000USD—2,000USD-1,000USD-2,000USD
Research Development2,116,000USD1,309,000USD558,000USD1,429,000USD987,000USD804,000USD1,036,000USD611,000USD
Selling General Administrative4,745,000USD3,813,000USD4,569,000USD2,808,000USD2,743,000USD2,943,000USD2,598,000USD2,411,000USD
Total Operating Expenses6,931,000USD5,020,000USD5,069,000USD4,222,000USD3,730,000USD3,847,000USD3,633,000USD3,020,000USD
Operating Income-6,505,000USD-4,748,000USD-4,594,000USD-4,118,000USD-3,730,000USD-3,847,000USD-3,634,000USD-3,022,000USD
Total Other Income Expense Net-10,018,000USD3,318,000USD4,954,000USD-1,772,000USD-13,851,000USD-1,665,000USD-5,444,000USD1,399,000USD
Interest Income6,000USD5,000USD4,000USD2,000USD2,000USD4,000USD4,000USD6,000USD
Interest Expense240,000USD233,000USD671,000USD0USD0USD0USD0USD0USD
Litigation Settlement Expense4,000USD———————
Income Before Tax-16,523,000USD-1,430,000USD360,000USD-5,890,000USD-17,581,000USD-5,512,000USD-9,078,000USD-1,623,000USD
Income Tax Expense0USD———————
Equity Method Income Loss3,000USD———————
Net Income-16,520,000USD-1,430,000USD360,000USD-5,890,000USD-17,581,000USD-5,512,000USD-9,078,000USD-1,623,000USD
Net Interest Income—-228,000USD-667,000USD2,000USD2,000USD4,000USD4,000USD6,000USD
Net Income From Continuing Ops—-1,430,000USD360,000USD-5,890,000USD-17,581,000USD-5,512,000USD-9,078,000USD-1,623,000USD
Ebit—-4,748,000USD-4,594,000USD-4,118,000USD-3,730,000USD-9,078,000USD-9,078,000USD-1,623,000USD
Ebitda—-4,583,000USD-4,494,000USD-4,077,000USD-17,581,000USD-5,512,000USD-9,077,000USD-1,621,000USD
Depreciation And Amortization—165,000USD100,000USD41,000USD—1,000USD1,000USD2,000USD
Reconciled Depreciation—165,000USD100,000USD43,000USD-1,000USD1,000USD1,000USD2,000USD
Selling And Marketing Expenses—————1,000USD1,000USD—
SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Income Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Total Revenue1,225,000USD0USD0USD0USD0USD0USD——
Cost Of Revenue505,000USD5,000USD5,000USD4,000USD2,000USD2,000USD—1,006,503USD
Gross Profit720,000USD-5,000USD-5,000USD-4,000USD-2,000USD-2,000USD—-1,006,503USD
Research Development3,777,000USD6,199,000USD13,371,000USD17,027,000USD20,257,000USD10,625,000USD3,496USD—
Selling General Administrative13,061,000USD13,505,000USD14,216,000USD27,370,000USD74,944,000USD11,436,000USD2,767USD1,006,500USD
Total Operating Expenses16,944,000USD19,699,000USD27,582,000USD44,331,000USD95,199,000USD22,059,000USD713,187USD1,006,502USD
Operating Income-16,224,000USD-19,704,000USD-27,587,000USD-44,335,000USD-95,201,000USD-22,061,000USD-713,187USD-1,006,500USD
Interest Income12,000USD44,000USD550,000USD249,000USD0USD138,760USD1,205,820USD1,088,920USD
Interest Expense671,000USD1,079,000USD120,000USD4,581,000USD18,000USD56,000USD0USD0USD
Net Interest Income-659,000USD-186,000USD513,000USD249,000USD-18,000USD-56,000USD——
Income Before Tax-28,622,000USD-25,126,000USD-30,150,000USD-39,754,000USD-93,063,000USD-51,777,000USD492,633USD82,412USD
Net Income-28,622,000USD-25,126,000USD-30,150,000USD-39,754,000USD-93,063,000USD-51,777,000USD408,427USD66,101USD
Net Income From Continuing Ops-28,622,000USD-25,126,000USD-36,059,000USD-39,754,000USD-93,063,000USD-1,089,510USD——
Ebit-27,951,000USD-24,047,000USD-30,030,000USD-39,754,000USD-93,045,000USD-51,721,000USD-713,188USD-1,006,503USD
Ebitda-27,808,000USD-24,042,000USD-30,025,000USD-39,750,000USD-93,043,000USD-51,719,000USD492,633USD82,412USD
Depreciation And Amortization143,000USD5,000USD5,000USD4,000USD2,000USD2,000USD1USD1,088,915USD
Reconciled Depreciation143,000USD5,000USD5,000USD4,000USD2,000USD2,000USD——
Total Other Income Expense Net-12,398,000USD-5,422,000USD-2,563,000USD4,581,000USD2,138,000USD-29,716,000USD1,205,820USD1,088,912USD
Selling And Marketing Expenses——5,000USD—————
Income Tax Expense——-9,000USD-4,581,000USD-21,348,000USD-39,430,000USD84,206USD16,311USD
Tax Provision———0USD0USD17,840USD84,210USD16,310USD
Net Income Applicable To Common Shares———-39,754,000USD-348,885,000USD-51,776,904USD-6,729,161USD66,100USD
Non Operating Income Net Other—————-303,027USD——
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
Total Assets34,160,000USD11,903,000USD12,956,000USD14,996,000USD4,838,000USD7,590,000USD3,651,000USD4,462,000USD
Cash And Equivalents26,686,000USD———————
Total Current Assets29,158,000USD7,361,000USD8,892,000USD11,947,000USD4,590,000USD7,256,000USD3,302,000USD4,106,000USD
Other Current Assets2,266,000USD467,000USD934,000USD4,524,000USD1,680,000USD1,708,000USD1,859,000USD2,454,000USD
Other Non Current Assets224,000USD———————
Total Liabilities34,330,000USD———————
Total Current Liabilities33,874,000USD25,176,000USD28,578,000USD40,593,000USD40,453,000USD32,751,000USD21,863,000USD20,299,000USD
Total Stockholder Equity-170,000USD-13,816,000USD-15,937,000USD-25,755,000USD-35,615,000USD-25,161,000USD-23,223,000USD-18,822,000USD
Total Equity Including Noncontrolling Interest-170,000USD———————
Net Receivables206,000USD181,000USD161,000USD239,000USD——0USD6,000USD
Property Plant Equipment Net919,000USD936,000USD696,000USD350,000USD——10,000USD—
Goodwill1,793,000USD———————
Intangible Assets832,000USD879,000USD925,000USD1,777,000USD————
Accounts Payable3,146,000USD4,399,000USD4,270,000USD4,257,000USD3,630,000USD4,311,000USD4,130,000USD4,866,000USD
Common Stock43,000USD33,000USD32,000USD28,000USD19,000USD17,000USD15,000USD11,000USD
Retained Earnings-324,845,000USD-308,325,000USD-306,895,000USD-307,256,000USD-301,366,000USD-283,785,000USD-278,273,000USD-269,195,000USD
Total Liab—25,719,000USD28,893,000USD40,751,000USD40,453,000USD32,751,000USD26,874,000USD23,284,000USD
Other Current Liab—20,386,000USD23,992,000USD36,147,000USD26,591,000USD20,043,000USD16,167,000USD11,749,000USD
Capital Stock—33,000USD32,000USD28,000USD19,000USD17,000USD15,000USD11,000USD
Good Will—1,793,000USD1,793,000USD610,000USD——0USD—
Cash—6,713,000USD7,797,000USD7,184,000USD2,910,000USD5,548,000USD1,443,000USD1,646,000USD
Cash And Short Term Investments—6,713,000USD7,797,000USD7,184,000USD2,910,000USD5,548,000USD1,443,000USD1,646,000USD
Net Debt—-5,779,000USD-7,166,000USD-6,837,000USD7,322,000USD2,849,000USD5,134,000USD5,023,000USD
Short Term Debt—391,000USD316,000USD189,000USD10,232,000USD8,397,000USD1,566,000USD3,684,000USD
Short Long Term Debt Total—934,000USD631,000USD347,000USD10,232,000USD8,397,000USD6,577,000USD6,669,000USD
Long Term Investments—399,000USD397,000USD———0USD—
Property Plant Equipment Gross—1,242,000USD696,000USD419,000USD——10,000USD—
Common Stock Shares Outstanding—32,325,323shares31,734,333shares22,231,178shares17,934,196shares16,410,000shares10,517,000shares10,974,000shares
Non Current Assets Total—4,542,000USD4,064,000USD3,049,000USD248,000USD334,000USD349,000USD356,000USD
Non Current Liabilities Total—543,000USD315,000USD158,000USD0USD5,011,000USD5,011,000USD2,985,000USD
Non Currrent Assets Other—535,000USD253,000USD312,000USD248,000USD334,000USD349,000USD356,000USD
Net Working Capital—-17,815,000USD-19,686,000USD-28,646,000USD-35,863,000USD-25,495,000USD-18,561,000USD-16,193,000USD
Unclassified Equity—294,443,000USD290,894,000USD281,445,000USD265,713,000USD258,590,000USD255,020,000USD250,351,000USD
Short Long Term Debt———10,061,000USD10,232,000USD8,397,000USD1,566,000USD3,684,000USD
Unclassified Current Liabilities———-10,061,000USD-10,232,000USD-8,397,000USD-1,566,000USD-3,684,000USD
Unclassified Non Current Liabilities—————5,011,000USD——
Long Term Debt——————5,011,000USD2,985,000USD
SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Total Assets12,956,000USD3,651,000USD7,315,000USD25,816,000USD32,729,000USD2,941,000USD32,074,694USD70,796,159USD
Intangible Assets925,000USD———————
Other Current Assets934,000USD1,859,000USD2,283,000USD5,734,000USD5,109,000USD26,000USD69,483USD19,114USD
Total Liab28,893,000USD26,874,000USD19,048,000USD18,407,000USD11,923,000USD46,712,000USD2,574,205USD1,257,410USD
Total Stockholder Equity-15,937,000USD-23,223,000USD-11,733,000USD7,409,000USD20,806,000USD-43,771,000USD29,500,489USD69,538,749USD
Other Current Liab23,992,000USD16,167,000USD5,255,000USD5,806,000USD7,718,000USD42,710,358USD622,441USD16,311USD
Common Stock32,000USD15,000USD84,000USD67,000USD59,000USD43,000USD24,503,332USD64,541,467USD
Capital Stock32,000USD15,000USD87,000USD67,000USD59,000USD43,000USD——
Retained Earnings-306,895,000USD-278,273,000USD-253,147,000USD-222,997,000USD-183,243,000USD-90,180,000USD369,495USD-38,932USD
Good Will1,793,000USD0USD——————
Cash7,797,000USD1,443,000USD4,595,000USD20,054,000USD27,605,000USD1,859,000USD6USD11,079USD
Cash And Short Term Investments7,797,000USD1,443,000USD4,595,000USD20,054,000USD27,605,000USD1,859,000USD6USD11,079USD
Total Current Assets8,892,000USD3,302,000USD6,884,000USD25,795,000USD32,714,000USD2,930,000USD69,489USD30,193USD
Total Current Liabilities28,578,000USD21,863,000USD19,048,000USD15,585,000USD11,923,000USD46,164,000USD622,441USD567,410USD
Net Debt-7,166,000USD5,134,000USD4,566,000USD-9,529,000USD-27,087,000USD-1,062,000USD1,951,758USD678,921USD
Short Term Debt316,000USD1,566,000USD9,161,000USD7,703,000USD518,000USD249,000USD——
Short Long Term Debt Total631,000USD6,577,000USD9,161,000USD10,525,000USD518,000USD797,000USD1,951,764USD690,000USD
Long Term Investments397,000USD0USD——————
Net Receivables161,000USD0USD6,000USD7,000USD0USD831,000USD——
Accounts Payable4,270,000USD4,130,000USD4,632,000USD2,076,000USD3,687,000USD3,153,000USD622,441USD551,099USD
Property Plant Equipment Net633,000USD10,000USD——————
Property Plant Equipment Gross696,000USD10,000USD——————
Common Stock Shares Outstanding21,401,683shares10,517,000shares7,576,000shares65,767,000shares46,918,000shares546,586shares508,835shares892,496shares
Non Current Assets Total4,064,000USD349,000USD431,000USD21,000USD15,000USD11,000USD32,005,205USD70,765,966USD
Non Current Liabilities Total315,000USD5,011,000USD0USD2,822,000USD4,205,000USD548,000USD1,951,764USD690,000USD
Non Currrent Assets Other316,000USD349,000USD431,000USD21,000USD15,000USD11,000USD1USD-234,034USD
Net Working Capital-19,686,000USD-18,561,000USD-12,164,000USD10,210,000USD20,791,000USD-43,234,000USD——
Unclassified Equity290,894,000USD255,020,000USD241,246,000USD230,272,000USD203,931,000USD46,323,000USD29,130,996USD5,036,214USD
Short Long Term Debt—1,566,000USD9,161,000USD7,703,000USD518,000USD249,000USD——
Long Term Debt—5,011,000USD—2,822,000USD—2,672,040USD1,951,760USD690,000USD
Unclassified Current Liabilities—-1,566,000USD-9,161,000USD-7,703,000USD-3,362,000USD———
Inventory——-6,000USD-7,000USD—214,000USD——
Accumulated Other Comprehensive Income——-3,000USD———-24,503,334USD—
Other Assets———0USD15,000USD0USD10,930USD—
Net Tangible Assets———7,409,000USD20,806,000USD-43,780,843USD-4,853,317USD—
Current Deferred Revenue————2,844,000USD———
Unclassified Non Current Liabilities————4,205,000USD-2,124,040USD——
Short Term Investments—————5,967,947USD32,005,205USD70,765,966USD
Unclassified Current Assets—————-5,967,947USD-32,005,205USD-70,765,966USD
Unclassified Non Current Assets——————31,994,274USD70,765,966USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow YTD

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USD
Depreciation134,000USD
Stock Based Compensation290,000USD
Other Non Cash Items0USD
Change To Account Receivables-98,000USD
Change To Liabilities-1,424,000USD
Change In Working Capital-2,614,000USD
Operating Cash Flow-13,170,000USD
Capital Expenditures-897,000USD
Investing Cash Flow-897,000USD
Financing Cash Flow32,956,000USD
Change In Cash18,889,000USD
End Cash Flow26,686,000USD
SourceDisclosureDeterministicFinal

Cash flow Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
Net Income-1,430,000USD360,000USD-5,890,000USD-17,580,000USD-5,512,000USD-9,078,000USD-1,623,000USD-7,897,000USD
Depreciation165,000USD100,000USD41,000USD-1,000USD1,000USD1,000USD2,000USD1,000USD
Stock Based Compensation151,000USD81,000USD68,000USD67,000USD12,000USD43,000USD104,000USD97,000USD
Other Non Cash Items-3,512,000USD-5,612,000USD2,391,000USD14,001,000USD2,020,000USD7,022,000USD-1,141,000USD2,190,000USD
Change To Account Receivables-48,000USD36,000USD12,000USD—0USD———
Change In Working Capital331,000USD1,358,000USD567,000USD-516,000USD548,000USD-86,000USD352,000USD2,104,000USD
Total Cash From Operating Activities-4,295,000USD-3,713,000USD-2,891,000USD-4,028,000USD-3,480,000USD-2,098,000USD-2,306,000USD-3,505,000USD
Capital Expenditures0USD0USD0USD0USD0USD0USD0USD0USD
Free Cash Flow-4,295,000USD-3,713,000USD-2,891,000USD-4,028,000USD-3,480,000USD-2,098,000USD-2,306,000USD-3,505,000USD
Investments-213,000USD———0USD0USD0USD0USD
Total Cashflows From Investing Activities-213,000USD-249,000USD-2,561,000USD—————
Net Borrowings0USD196,000USD-575,000USD378,000USD4,680,000USD884,000USD-224,000USD—
Total Cash From Financing Activities3,424,000USD4,575,000USD9,726,000USD1,390,000USD7,585,000USD1,895,000USD2,054,000USD4,083,999USD
Issuance Of Capital Stock3,424,000USD1,641,000USD9,952,000USD1,012,000USD3,255,000USD0USD219,000USD3,142,000USD
Change In Cash-1,084,000USD613,000USD4,274,000USD-2,638,000USD4,105,000USD-203,000USD-252,000USD579,000USD
Begin Period Cash Flow7,797,000USD7,184,000USD2,910,000USD5,548,000USD1,443,000USD1,646,000USD1,898,000USD1,319,000USD
End Period Cash Flow6,713,000USD7,797,000USD7,184,000USD2,910,000USD5,548,000USD1,443,000USD1,646,000USD1,898,000USD
Other Cashflows From Investing Activities-213,000USD-432,000USD——————
Other Cashflows From Financing Activities3,424,000USD1,000USD-1,000USD—-350,000USD1,011,000USD2,368,000USD—
Unclassified Financing Cash Flow-3,424,000USD2,737,000USD——————
Unclassified Investing Cash Flow——-2,561,000USD—————
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Net Income-28,622,000USD-25,126,000USD-30,150,000USD-39,754,000USD-93,063,000USD-51,777,000USD408,427USD66,101USD
Depreciation143,000USD5,000USD5,000USD4,000USD2,000USD2,000USD1USD—
Stock Based Compensation228,000USD486,000USD387,000USD3,628,000USD7,785,000USD730,000USD934USD—
Other Non Cash Items12,730,000USD8,707,000USD2,937,000USD-4,332,000USD52,471,000USD45,327,000USD-1,205,820USD-1,554,343USD
Change To Account Receivables48,000USD0USD—0USD831,000USD-831,000USD-831,390USD—
Change In Working Capital1,409,000USD5,291,000USD5,164,000USD699,000USD-4,898,000USD3,453,000USD4,662USD549,627USD
Total Cash From Operating Activities-14,112,000USD-10,637,000USD-21,657,000USD-39,755,000USD-37,703,000USD-2,265,000USD-792,731USD-473,187USD
Capital Expenditures0USD0USD-3,000USD-10,000USD-7,000USD-2,000USD-1USD0USD
Free Cash Flow-14,112,000USD-10,637,000USD-21,660,000USD-39,765,000USD-37,710,000USD-2,267,000USD-792,730USD-473,187USD
Investments-432,000USD0USD-3,000USD-10,000USD-7,000USD-282,626USD——
Total Cashflows From Investing Activities-2,810,000USD—-3,000USD-10,000USD-7,000USD-2,000USD40,246,581USD-647,608USD
Net Borrowings4,679,000USD-1,496,000USD-3,092,000USD9,502,000USD-1,276,000USD619,842USD619,842USD—
Total Cash From Financing Activities23,276,000USD7,485,000USD6,201,000USD32,214,000USD63,456,000USD3,249,000USD-39,464,923USD682,500USD
Issuance Of Capital Stock15,860,000USD5,911,000USD9,385,000USD22,702,000USD36,983,000USD2,629,000USD——
Change In Cash6,354,000USD-3,152,000USD-15,459,000USD-7,551,000USD25,746,000USD982,000USD-11,073USD-438,295USD
Begin Period Cash Flow1,443,000USD4,595,000USD20,054,000USD27,605,000USD1,859,000USD877,000USD11,079USD449,374USD
End Period Cash Flow7,797,000USD1,443,000USD4,595,000USD20,054,000USD27,605,000USD1,859,000USD6USD11,079USD
Other Cashflows From Investing Activities-432,000USD——10,000USD7,000USD26,176,022USD4USD-647,608USD
Other Cashflows From Financing Activities23,276,000USD3,070,000USD1,171,000USD10,000USD27,749,000USD50,000USD1,261,764USD682,500USD
Unclassified Investing Cash Flow-1,946,000USD————-25,893,396USD40,246,578USD—
Unclassified Financing Cash Flow-20,539,000USD—-1,263,000USD——28,876,376USD——
Change To Liabilities———0USD-19,000USD1,183,143USD-52,181USD—
Sale Purchase Of Stock—————-26,297,218USD-40,726,687USD—
Cash And Cash Equivalents Changes—————460USD——
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Operating metrics

No operating metrics are currently published for this company.

Revenue breakdown

PeriodDimensionBusiness / regionRevenueCurrencySource
Q1 2026Quarterly · 2026-03-31ProductProcedures308,000USD0001437749-26-017397
Q1 2026Quarterly · 2026-03-31ProductTherapy760,000USD0001437749-26-017397
FY 2025Yearly · 2025-12-31ProductProcedures371,000USD0001437749-26-009418
FY 2025Yearly · 2025-12-31ProductTherapy854,000USD0001437749-26-009418
Q3 2025Quarterly · 2025-09-30ProductProcedures90,000USD0001437749-25-035210
Q3 2025Quarterly · 2025-09-30ProductTherapy152,000USD0001437749-25-035210

Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.